American and Malian scientist malaria vaccine clinical trial make the new development

American and Malian scientist malaria vaccine clinical trial make the new development

The American and Malian scientist special despatch on February 3 of www.xinhuanet.com Washington is released a report and said jointly on the 2nd, a kind of malaria vaccine developed together by the scientists of two countries stimulates strong immunoreaction in Malian children's body.
Two countries scientist write articles to point out at " whether public the intersection of science and library synthesize " in international the intersection of authority and academic periodical that publish recently, they choose Mali 100 1 year old get 6 -year-old children inoculate different malignant the intersection of plasmodium and vaccine of dosage ' Malignant plasmodium is the most common and also the most fatal parasite of Africa area) ,The result reveals, vaccine of different dosage demonstrates good tolerance, stimulate strong immunoreaction, the intersection of immunity and at least one year continuously in the body in children.
Study, show still, the intersection of antibody and density that produce equal to even greater than those, live in the intersection of malaria and area producing immune adulting of ability naturally for a long time already in the body in children.
Main author Christopher general Lip river in this report is said: "This means we have perhaps already achieved the goal of studying, namely stimulate, appear with one vaccine adult need, in the intersection of malaria and intensive area could live natural antibody that produce several year usually. "
What malaria is initiated by plasmodium, biting infectious disease spreading through the mosquito. The statistics show, nearly 500 million people are infected with malaria every year in the whole world, about 1 million people die of malaria. For a long time, the medical circle has been devoted to the vaccine development of malaria all the time, but progress is overall slowly.
It carries on whom vaccine of test directed primarily to to be whether plasmodium invade stage after blood breed in Mali this time. Because the small-scale test succeeds, the scientist plans to carry on the clinical trial to 400 children in Mali.
|